Physician profile
Donna Bennett
NPI 1568446995
$694.95
in general payments reported to CMS, 2019-2025
14 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $49.29 · 2021: $38.20 · 2022: $104 · 2023: $63.98 · 2024: $203 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $131.29 | 2020-2023 | Nucala |
| Mayne Pharma Commercial LLC | $121.83 | 2024 | |
| Hologic Sales and Service, LLC | $88.24 | 2025 | Aptima, Thinprep 2000 Processor |
| Astrazeneca Pharmaceuticals Lp | $87.41 | 2022 | |
| Medtronic, INC. | $62.08 | 2024-2025 | Interstim |
| Astellas Pharma US INC | $38.94 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $29.29 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $24.59 | 2025 | |
| Millicent US INC | $24.47 | 2025 | Intrarosa, Femlyv |
| Merck Sharp & Dohme LLC | $19.90 | 2020 | |
| Sumitomo Pharma America, INC. | $17.38 | 2024 | Myfembree |
| Daiichi Sankyo INC. | $17.36 | 2020 | |
| Exeltis, USA INC. | $16.22 | 2025 | Slynd |
| Evofem Biosciences, INC. | $15.95 | 2025 | Solosec, Phexx, Phexxi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.